SNS-032

Investigational

Details

Stereochemistry	ACHIRAL
Molecular Formula	C17H24N4O2S2
Molecular Weight	380.528
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC(C)(C)C1=CN=C(CSC2=CN=C(NC(=O)C3CCNCC3)S2)O1

InChI

InChIKey=OUSFTKFNBAZUKL-UHFFFAOYSA-N

InChI=1S/C17H24N4O2S2/c1-17(2,3)12-8-19-13(23-12)10-24-14-9-20-16(25-14)21-15(22)11-4-6-18-7-5-11/h8-9,11,18H,4-7,10H2,1-3H3,(H,20,21,22)

HIDE SMILES / InChI

Molecular Formula	C17H24N4O2S2
Molecular Weight	380.528
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19169685 | https://www.ncbi.nlm.nih.gov/pubmed/15027863 | http://adisinsight.springer.com/drugs/800016657 | https://www.ncbi.nlm.nih.gov/pubmed/17938863

SNS-032 (formerly BMS-387032) is a potent, selective inhibitor of cyclin-dependent kinases (CDK). SNS-032 blocks the cell cycle via inhibition of CDKs 2 and 7, and transcription via inhibition of CDKs 7 and 9. SNS-032 was investigated for the treatment of solid tumors and hematologic malignancies (Phase I studies), however, its development was discontinued.

CNS Activity

Originator

Approval Year

Targets

Primary Target	Pharmacology	Potency
Cyclin-dependent kinase 2/cyclin E 10 Target ID: CHEMBL2094126 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15027863	Inhibitor 8297	48.0 nM [IC50]
CDK9/cyclin T1 4 Target ID: CHEMBL2111389 Sources: https://www.sunesis.com/data-pdf/032/poster5_04_06.pdf \| https://www.ncbi.nlm.nih.gov/pubmed/19169685	Inhibitor 8297	5.0 nM [Ki]
CDK2/Cyclin A 7 Target ID: CHEMBL3038469 Sources: https://www.sunesis.com/data-pdf/032/poster5_04_06.pdf \| https://www.ncbi.nlm.nih.gov/pubmed/19169685	Inhibitor 8297	70.0 nM [Ki]
Cyclin-dependent kinase 7/ cyclin H 7 Target ID: CHEMBL2111288 Sources: https://www.sunesis.com/data-pdf/032/poster5_04_06.pdf \| https://www.ncbi.nlm.nih.gov/pubmed/19169685	Inhibitor 8297	60.0 nM [Ki]

Conditions

Condition	Modality	Targets	Highest Phase	Product
Cancer 592 Sources: https://www.ncbi.nlm.nih.gov/pubmed/17938863 http://adisinsight.springer.com/drugs/800016657	Primary		Phase I 428	Unknown Approved Use Unknown
Hematologic malignancies 19 Sources: https://www.ncbi.nlm.nih.gov/pubmed/17938863 http://adisinsight.springer.com/drugs/800016657	Primary		Phase I 428	Unknown Approved Use Unknown

C_max

Value	Dose	Co-administered	Analyte	Population
0.017 μg/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/17938863	16 mg/m² single, oral dose: 16 mg/m² route of administration: Oral experiment type: SINGLE co-administered:		SNS-032 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED
0.287 μg/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/17938863	16 mg/m² single, intravenous dose: 16 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered:		SNS-032 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN

AUC

Value	Dose	Co-administered	Analyte	Population
0.052 μg × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/17938863	16 mg/m² single, oral dose: 16 mg/m² route of administration: Oral experiment type: SINGLE co-administered:		SNS-032 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED
0.553 μg × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/17938863	16 mg/m² single, intravenous dose: 16 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered:		SNS-032 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN

T_1/2

Value	Dose	Co-administered	Analyte	Population
8.5 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/17938863	16 mg/m² single, oral dose: 16 mg/m² route of administration: Oral experiment type: SINGLE co-administered:		SNS-032 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED
9.1 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/17938863	16 mg/m² single, intravenous dose: 16 mg/m² route of administration: Intravenous experiment type: SINGLE co-administered:		SNS-032 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN

F_unbound

Value	Dose	Co-administered	Analyte	Population
37% EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/15027863	unknown, unknown		SNS-032 serum	Homo sapiens population: UNKNOWN age: UNKNOWN sex: UNKNOWN food status: UNKNOWN

Sourcing

Vendor/Aggregator	ID	URL
1PlusChem LLC	1P00C6YD	https://www.1pchem.com/search?query=1P00C6YD
A2B Chem	AF68085	http://a2bchem.com/prod/AF68085
AChemBlock	10384	http://www.achemblock.com/catalogsearch/result/?q=10384
AK Scientific	SYN1080	https://aksci.com/item_detail.php?cat=SYN1080
AK Scientific	X7382	https://aksci.com/item_detail.php?cat=X7382
Ambeed	A153280	http://www.ambeed.com/search/Search.html?keyword=A153280
ApexBio Technology	A1980	https://www.apexbt.com/catalogsearch/result/?q=A1980
AstaTech	41327	http://astatechinc.com/CPSResult.php?CRNO=41327
Axon MedChem	1614	https://www.axonmedchem.com/product/1614
BLD Pharm	BD165410	http://www.bldpharm.com/search/Search.html?keyword=BD165410
BOC Sciences	345627-80-7	http://www.bocsci.com/description.asp?cas=345627-80-7
Capot Chemical	16670	https://www.capotchem.com/search.do?q=16670
Cayman Chemical	17904	http://www.caymanchem.com/app/template/Product.vm/catalog/17904
Chem Scene	CS-0021	http://www.chemscene.com/goproductList/searchProductList?productObj=CS-0021
ChemShuttle	109817	https://www.chemshuttle.com/catalogsearch/result/?q=109817
ChemShuttle	149126	https://www.chemshuttle.com/catalogsearch/result/?q=149126
Combi-Blocks	QJ-1343	http://www.combi-blocks.com/cgi-bin/find.cgi?QJ-1343
Excenen	EX-A054	http://www.excenen.com/searchresultlist.php?id=EX-A054
Fluorochem	240573	http://www.fluorochem.co.uk/Products/Product?code=240573
Hairui	HR110690	http://www.hairuichem.com/en/product/search.do?q=HR110690
Hairui	HR121225	http://www.hairuichem.com/en/product/search.do?q=HR121225
KeyOrganics	AS-16235	http://www.keyorganicsinc.com/bionet/catalogsearch/result?q=AS-16235
KeyOrganics	AS-35116	http://www.keyorganicsinc.com/bionet/catalogsearch/result?q=AS-35116
Lab Network	LN01304605	https://labnetwork.com/frontend-app/p/#!/moleculedetails/LN01304605
Lab Seeker	SC-84716	http://www.labseeker.com/search.php?keywords=SC-84716&category=0
LabSeeker	SC-84716	http://www.labseeker.com/search.php?keywords=SC-84716&category=0
Matrix Scientific	146701	http://www.matrixscientific.com/146701.html
MedChem Express	HY-10008	https://www.medchemexpress.com/search.html?q=HY-10008&ft=&fa=&fp=
MolPort	MolPort-005-942-660	https://www.molport.com/shop/molecule-link/MolPort-005-942-660
MolPort	MolPort-039-062-140	https://www.molport.com/shop/molecule-link/MolPort-039-062-140
Molnova	M14183	https://www.molnova.com/en/serch-list.html?keywords=M14183
MuseChem	I003261	https://www.musechem.com/product/I003261.html
ShangHai Biochempartner	BCP000203	http://www.biochempartner.com/search_BCP000203
ShangHai Biochempartner	BCP000355	http://www.biochempartner.com/search_BCP000355
ShangHai Biochempartner	BCP01951	http://www.biochempartner.com/search_BCP01951
ShangHai Biochempartner	BCP02418	http://www.biochempartner.com/search_BCP02418
ShangHai Biochempartner	BCP06530	http://www.biochempartner.com/search_BCP06530
TargetMol	T6049	https://www.targetmol.com/search?keyword=T6049
Tocris	4075	https://www.tocris.com/search.php?Type=QuickSearch&Value=4075
Toronto Research Chemicals	S590100	https://www.trc-canada.com/product-detail/?CatNum=S590100
W&J PharmaChem	50C1004546	http://wjpharmachem.com/new/searcht.php?keyword=50C1004546
eMolecules	10705199	https://orderbb.emolecules.com/search/#?query=10705199
eMolecules	31507563	https://orderbb.emolecules.com/search/#?query=31507563
eMolecules	44696712	https://orderbb.emolecules.com/search/#?query=44696712
eNovation Chemicals	D320225	https://www.enovationchem.com/Products.asp?SEARCHTEXT=D320225&searchbtn.x=0&searchbtn.y=0
eNovation Chemicals	D552382	https://www.enovationchem.com/Products.asp?SEARCHTEXT=D552382&searchbtn.x=0&searchbtn.y=0
eNovation Chemicals	D663018	https://www.enovationchem.com/Products.asp?SEARCHTEXT=D663018&searchbtn.x=0&searchbtn.y=0
mcule	MCULE-3980461563	https://mcule.com/MCULE-3980461563/
mcule	MCULE-7173755768	https://mcule.com/MCULE-7173755768/

PubMed

Title	Date	PubMed
		252160300
Mechanism of action of SNS-032, a novel cyclin-dependent kinase inhibitor, in chronic lymphocytic leukemia.	2009 May 7	19234140
The small-molecule CDK inhibitor, SNS-032, enhances cellular radiosensitivity in quiescent and hypoxic non-small cell lung cancer cells.	2009 Oct	19193471
SNS-032 is a potent and selective CDK 2, 7 and 9 inhibitor that drives target modulation in patient samples.	2009 Sep	19169685
Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry.	2010 Nov 24	21095574
Comprehensive analysis of kinase inhibitor selectivity.	2011 Oct 30	22037378

Patents

Sample Use Guides

In Vivo Use Guide

Patients with metastatic solid tumors or refractory lymphoma were treated with a starting dose of 4 mg/m2 intravenously administered over 1-h with a cycle defined as 3 weekly doses of SNS-032 every 21 days. Three patient cohorts were utilized in the dose-escalation schema. Pharmacokinetic studies were performed. For the 13 and 16 mg/m2 dose cohorts, the first dose of cycle 2 was given as an oral solution to estimate the oral bioavailability of the drug in humans.

Route of Administration: Other

In Vitro Use Guide

Treatment of RPMI-8226 MM cells with 300 nM SNS-032 (IC(90)) for 6 h was sufficient for commitment to apoptosis. Antiproliferative activity was established in an A2780 cellular cytotoxicity assay in which SNS-032 showed an IC(50) = 95 nM.

Substance Class	Chemical Created by `admin` on `Fri Dec 15 19:22:14 GMT 2023` Edited by `admin` on `Fri Dec 15 19:22:14 GMT 2023`
Record UNII	9979I93686
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

SNS-032

Common Name

English

BMS387032

Common Name

English

N-(5-(((5-(1,1-DIMETHYLETHYL)-2-OXAZOLYL)METHYL)THIO)-2-THIAZOLYL)-4-PERIDINECARBOXAM

Common Name

English

BMS-387032

Common Name

English

SNS 032 [WHO-DD]

Common Name

English

4-PIPERIDINECARBOXAMIDE, N-(5-(((5-(1,1-DIMETHYLETHYL)-2-OXAZOLYL)METHYL)THIO)-2-THIAZOLYL)-

Systematic Name

English

Code System Code Type Description

FDA UNII

9979I93686